Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indofarma Tbk. (INAF) vs Multi Indocitra Tbk. (MICE) Price & Performance

Indofarma Tbk.Trade
Multi Indocitra Tbk.Trade

Price performance (Past 24H)

Key statistics

Indofarma Tbk. vs Multi Indocitra Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Multi Indocitra Tbk. trades at Rp540 (market cap 336B, 8.4K 24h volume). The key difference: Indofarma Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.

INAFMICE
Market Cap
390.51B336B
Volume
8.4K
Lot
84
Turnover
4.58M
Average Price
545.54
Value
4.58M

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INAF
View details
MICE
View details

About Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Read more on INAF

About Multi Indocitra Tbk.

PT Multi Indocitra Tbk (the Company) was established under its original name of Modern Indocitra based on notarial deed No. 52 of Esther Daniar Iskandar, S.H dated January 11, 1990. The Company's articles of association has been amended several times, the latest amendment dated Aug 16, 2005, regarding the change in the Company's status from private company to public company.

Read more on MICE